The American Hospital of Paris, founded in 1906, is a private, not-for-profit hospital that is certified under the French healthcare system. Located in Neuilly-sur-Seine, in the western suburbs of Paris, France, it has 187 surgical, medical, and obstetric beds.

There are 187 beds in American Hospital of Paris.

During the past decade, American Hospital of Paris conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 4 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "American Hospital of Paris" #1 sponsor was "GERCOR - Multidisciplinary Oncology Cooperative Group" with 10 trials, followed by "American Hospital of Paris" with 2 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 2 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "American Hospital of Paris" #1 collaborator was "American Hospital of Paris" with 1 trials as a collaborator, "CHU Nantes" with 1 trials as a collaborator, "Fondation avenir" with 1 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "The Lymphoma Study Association" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "American Hospital of Paris" are "Colorectal Cancer" (3 trials), "Lung Cancer" (3 trials), "Pancreatic Cancer" (3 trials), "Breast Fibroadenoma" (2 trials) and "ALK Gene Mutation" (1 trials). Many other conditions were trialed in "American Hospital of Paris" in a lesser frequency.

Most popular intervention types in "American Hospital of Paris" are "Drug" (19 trials), "Other" (6 trials), "Procedure" (5 trials), "Device" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "gemcitabine hydrochloride" (5 trials), "docetaxel" (4 trials), "fluorouracil" (3 trials), "leucovorin calcium" (3 trials) and "oxaliplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "American Hospital of Paris" are 28 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "American Hospital of Paris". 1 are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in American Hospital of Paris, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in American Hospital of Paris, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".

American Hospital of Paris has several departments that took part in Clinical trials: "Cardiology Department" - 4 trials, "Medical and surgical Intensive Care unit" - 2 trials, "Rhumathology department" - 2 trials